The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
MicroRNA-34a: a potential therapeutic target in human cancer
Open accessAbstract
MicroRNAs (miRs) are small noncoding RNAs that negatively regulate gene expression by binding to the three untranslated regions of their target mRNAs. Deregulations of miRs were shown to play pivotal roles in tumorigenesis and progression. Recent research efforts have been devoted to translating these basic discoveries into applications that could improve the therapeutic outcome of patients with cancer. MiR-34a is a highly conserved miR throughout many different species. In humans, there are three homologs (hsa-miR34a, hsa-miR-34b and hsa-miR-34c). Early studies have shown that miR-34a acts as a tumor-suppressor gene by targeting many oncogenes related to proliferation, apoptosis and invasion. In this review, we provide a complex overview of miR-34a, including regulating its expression, its known functions in cancer and future challenges as a potential therapeutic target in human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Maris, J. M., Hogarty, M. D., Bagatell, R., & Cohn, S. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60983-0 · Cited by 2,032
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
miRNAs, Cancer, and Stem Cell Division
Croce, C. M., & Calin, G. A. (2005) · Cell · doi:10.1016/j.cell.2005.06.036 · Cited by 1,329
New insights into TGF-β–Smad signalling
Dijke, P. T., & Hill, C. S. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.03.008 · Cited by 1,180
p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,123
A MicroRNA Signature of Hypoxia
Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto-Perez, F. J., Davuluri, R., Liu, C.-G., Croce, C. M., Negrini, M., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01395-06 · Cited by 1,055
Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., & Hermeking, H. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4436 · Cited by 923
Tazawa, H., Tsuchiya, N., Izumiya, M., & Nakagama, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707351104 · Cited by 903
Hypoxia signalling through mTOR and the unfolded protein response in cancer
Wouters, B. G., & Koritzinsky, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2501 · Cited by 894
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
Welch, C., Chen, Y., & Stallings, R. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210293 · Cited by 805
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Körner, H., Knyazev, P., Diebold, J., & Hermeking, H. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6533 · Cited by 784
Gaur, A., Jewell, D. A., Liang, Y., Ridzon, D., Moore, J. H., Chen, C., Ambros, V. R., & Israel, M. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2698 · Cited by 727
MicroRNA-directed transcriptional gene silencing in mammalian cells
Kim, D. H., Sætrom, P., Snøve, O., & Rossi, J. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808830105 · Cited by 705
Ambs, S., Prueitt, R. L., Yi, M., Hudson, R. S., Howe, T. M., Petrocca, F., Wallace, T. A., Liu, C.-G., Volinia, S., Calin, G. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0144 · Cited by 704
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 689
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Patrawala, L., Brown, D., & Bader, A. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0655 · Cited by 677
Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 667
Widespread deregulation of microRNA expression in human prostate cancer
Ozen, M., Creighton, C. J., Ozdemir, M., & Ittmann, M. (2008) · Oncogene · doi:10.1038/sj.onc.1210809 · Cited by 634
MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
Li, Y., Guessous, F., Zhang, Y., DiPierro, C., Kefas, B., Johnson, E., Marcinkiewicz, L., Jiang, J., Yang, Y., Schmittgen, T. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0529 · Cited by 614
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
Siemens, H., Jackstadt, R., Hünten, S., Kaller, M., Menssen, A., Götz, U., & Hermeking, H. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18552 · Cited by 609
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
Attiyeh, E. F., London, W. B., Mossé, Y. P., Wang, Q., Winter, C., Khazi, D., McGrady, P. W., Seeger, R. C., Look, A. T., Shimada, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052399 · Cited by 580
Eiring, A. M., Harb, J. G., Neviani, P., Garton, C., Oaks, J. J., Spizzo, R., Liu, S., Schwind, S., Santhanam, R., Hickey, C. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.007 · Cited by 560
MiR-34, SIRT1, and p53: The feedback loop
Yamakuchi, M., & Lowenstein, C. J. (2009) · Cell Cycle · doi:10.4161/cc.8.5.7753 · Cited by 468
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K., & Schwarzenbach, H. (2010) · Breast Cancer Research · doi:10.1186/bcr2766 · Cited by 430
Yin Yang 1 Is a Negative Regulator of p53
Sui, G., Affar, E. B., Shi, Y., Brignone, C., Wall, N. R., Yin, P., Donohoe, M., Luke, M. P., Calvo, D., Grossman, S. R., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.004 · Cited by 424
Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y., & Zheng, X. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.09.035 · Cited by 418
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC
Christoffersen, N. R., Shalgi, R., Frankel, L. B., Leucci, E., Lees, M., Klausen, M., Pilpel, Y., Nielsen, F. C., Oren, M., & Lund, A. H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.109 · Cited by 352
Zhang, H., Zhai, Y., Hu, Z., Wu, C., Qian, J., Jia, W., Ma, F., Huang, W., Yu, L., Yue, W., et al. (2010) · Nature Genetics · doi:10.1038/ng.638 · Cited by 346
Bidirectional Gene Organization
Adachi, N., & Lieber, M. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00758-4 · Cited by 346
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Gallardo, E., Navarro, A., Viñolas, N., Marrades, R. M., Diaz, T., Gel, B., Quera, A., Bandres, E., Garcia-Foncillas, J., Ramirez, J., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp219 · Cited by 342
Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Mediated Gene Regulation
Meijer, H. A., Kong, Y. W., Lu, W. T., Wilczynska, A., Spriggs, R. V., Robinson, S. W., Godfrey, J. D., Willis, A. E., & Bushell, M. (2013) · Science · doi:10.1126/science.1231197 · Cited by 326
A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene
Cole, K. A., Attiyeh, E. F., Mosse, Y. P., Laquaglia, M. J., Diskin, S. J., Brodeur, G. M., & Maris, J. M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2102 · Cited by 316
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
Corney, D. C., Hwang, C.-I., Matoso, A., Vogt, M., Flesken-Nikitin, A., Godwin, A. K., Kamat, A. A., Sood, A. K., Ellenson, L. H., Hermeking, H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2642 · Cited by 308
microRNA-34a is tumor suppressive in brain tumors and glioma stem cells
Guessous, F., Zhang, Y., Kofman, A., Catania, A., Li, Y., Schiff, D., Purow, B., & Abounader, R. (2010) · Cell Cycle · doi:10.4161/cc.9.6.10987 · Cited by 306
Genome-Wide Epigenetic Regulation of miRNAs in Cancer
Baer, C., Claus, R., & Plass, C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3731 · Cited by 297
Nalls, D., Tang, S.-N., Rodova, M., Srivastava, R. K., & Shankar, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024099 · Cited by 256
Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies
Wong, K. Y., So, C. C., Loong, F., Chung, L. P., Lam, W. W. L., Liang, R., Li, G. K. H., Jin, D.-Y., & Chim, C. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019027 · Cited by 247
Pang, R. T. K., Leung, C. O. N., Ye, T.-M., Liu, W., Chiu, P. C. N., Lam, K. K. W., Lee, K.-F., & Yeung, W. S. B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq066 · Cited by 242
Kato, M., Paranjape, T., Ullrich, R., Nallur, S., Gillespie, E., Keane, K., Esquela-Kerscher, A., Weidhaas, J. B., & Slack, F. J. (2009) · Oncogene · doi:10.1038/onc.2009.106 · Cited by 240
Di Martino, M. T., Leone, E., Amodio, N., Foresta, U., Lionetti, M., Pitari, M. R., Cantafio, M. E. G., Gullà, A., Conforti, F., Morelli, E., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1708 · Cited by 239
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1
Yang, S., Li, Y., Gao, J., Zhang, T., Li, S., Luo, A., Chen, H., Ding, F., Wang, X., & Liu, Z. (2013) · Oncogene · doi:10.1038/onc.2012.432 · Cited by 228
Defining Optimal Therapy for Muscle Invasive Bladder Cancer
Herr, H. W., Dotan, Z., Donat, S. M., & Bajorin, D. F. (2007) · Journal of Urology · doi:10.1016/j.juro.2006.09.027 · Cited by 226
Yan, D., Zhou, X., Chen, X., Hu, D.-N., Dong, X. D., Wang, J., Lu, F., Tu, L., & Qu, J. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2681 · Cited by 211
Kojima, K., Fujita, Y., Nozawa, Y., Deguchi, T., & Ito, M. (2010) · The Prostate · doi:10.1002/pros.21185 · Cited by 205
Intact p53-Dependent Responses in miR-34–Deficient Mice
Concepcion, C. P., Han, Y.-C., Mu, P., Bonetti, C., Yao, E., D'Andrea, A., Vidigal, J. A., Maughan, W. P., Ogrodowski, P., & Ventura, A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002797 · Cited by 197
The Quest for the 1p36 Tumor Suppressor
Bagchi, A., & Mills, A. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2095 · Cited by 196
Yan, K., Gao, J., Yang, T., Ma, Q., Qiu, X., Fan, Q., & Ma, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033778 · Cited by 195
Eichelser, C., Flesch-Janys, D., Chang-Claude, J., Pantel, K., & Schwarzenbach, H. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.205161 · Cited by 195
Genome wide association study identifies KCNMA1contributing to human obesity
Jiao, H., Arner, P., Hoffstedt, J., Brodin, D., Dubern, B., Czernichow, S., van't Hooft, F., Axelsson, T., Pedersen, O., Hansen, T., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-51 · Cited by 179
miRNA-34a is associated with docetaxel resistance in human breast cancer cells
Kastl, L., Brown, I., & Schofield, A. C. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1424-3 · Cited by 174
Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets
Agostini, M., Tucci, P., Killick, R., Candi, E., Sayan, B. S., Rivetti di val Cervo, P., Nicotera, P., McKeon, F., Knight, R. A., Mak, T. W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112061109 · Cited by 171
Du, R., Sun, W., Xia, L., Zhao, A., Yu, Y., Zhao, L., Wang, H., Huang, C., & Sun, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030771 · Cited by 169
Bandi, N., & Vassella, E. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-55 · Cited by 157
Epigenetic inactivation of the miR-34a in hematological malignancies
Chim, C. S., Wong, K. Y., Qi, Y., Loong, F., Lam, W. L., Wong, L., Jin, D., Costello, J., & Liang, R. H. S. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq033 · Cited by 157
Yamamura, S., Saini, S., Majid, S., Hirata, H., Ueno, K., Deng, G., & Dahiya, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029722 · Cited by 155
miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53
Navarro, F., Gutman, D. A., Meire, E., Cáceres, M., Rigoutsos, I., Bentwich, Z., & Lieberman, J. (2009) · Blood · doi:10.1182/blood-2009-02-205062 · Cited by 155
Nakatani, F., Ferracin, M., Manara, M. C., Ventura, S., Monaco, V. D., Ferrari, S., Alberghini, M., Grilli, A., Knuutila, S., Schaefer, K., et al. (2011) · The Journal of Pathology · doi:10.1002/path.3007 · Cited by 151
MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1
Wu, J., Wu, G., Lv, L., Ren, Y.-F., Zhang, X., Xue, Y.-F., Li, G., Lu, X., Sun, Z. S., & Tang, K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr304 · Cited by 145
Baer, C. R., Claus, R., Frenzel, L. P., Zucknick, M., Park, Y. J., Gu, L., Weichenhan, D., Fischer, M., Pallasch, C. P., Herpel, E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0803 · Cited by 138
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
Weeraratne, S. D., Amani, V. M., Neiss, A., Teider, N., Scott, D. K., Pomeroy, S. L., & Cho, Y. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq179 · Cited by 135
Platelet membrane proteomics: a novel repository for functional research
Lewandrowski, U., Wortelkamp, S., Lohrig, K., et al. (2009) · Blood · doi:10.1182/blood-2009-02-203828 · Cited by 133
Antonini, D., Russo, M. T., Rosa, L. D., Gorrese, M., Vecchio, L. D., & Missero, C. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.438 · Cited by 126
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
Tivnan, A., Tracey, L., Buckley, P. G., Alcock, L., Davidoff, A. M., & Stallings, R. L. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-33 · Cited by 126
MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251
Luan, S., Sun, L., & Huang, F. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.02.007 · Cited by 113
Vinall, R. L., Ripoll, A. Z., Wang, S., Pan, C.-X., & White, R. D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26256 · Cited by 111
Cheng, C.-Y., Hwang, C., Corney, D. C., Flesken‐Nikitin, A., Jiang, L., Öner, M. G., Munroe, R. J., Schimenti, J. C., Hermeking, H., & Nikitin, A. Y. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.023 · Cited by 110
Genovese, G., Ergün, A., Shukla, S. A., Campos, B., Hanna, J. A., Ghosh, P., Quayle, S. N., Rai, K., Colla, S., Ying, H., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0111 · Cited by 107
Nagai, H., Negrini, M., Carter, S. L., Gillum, D. R., Rosenberg, A., Schwartz, G. F., & Croce, C. M. (1995) · PubMed · Cited by 106
MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
Li, X., Ji, M., Zhong, S., Zha, Q.-B., Xu, J., Zhao, J., & Tang, J. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.09.007 · Cited by 103
Self-citationIchimura, A., Ruike, Y., Terasawa, K., Shimizu, K., & Tsujimoto, G. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.063321 · Cited by 94
MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame
Mandke, P., Wyatt, N., Fraser, J., Bates, B., Berberich, S. J., & Markey, M. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042034 · Cited by 92
Chen, G., Zhao, Z., Zhou, H., Liu, Y., & Yang, H. (2009) · Medical Oncology · doi:10.1007/s12032-009-9225-9 · Cited by 89
Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a
Chen, Q., Yu, L., Tsang, P., Wei, J. S., Song, Y., Cheuk, A., Chung, J., Hewitt, S. M., Veenstra, T. D., & Khan, J. I. (2010) · Journal of Proteome Research · doi:10.1021/pr1006697 · Cited by 89
Buanne, P., Corrente, G. A., Micheli, L., Palena, A., Lavia, P., Spadafora, C., Lakshmana, M. K., Rinaldi, A., Banfi, S., Quarto, M., et al. (2000) · Genomics · doi:10.1006/geno.2000.6288 · Cited by 70
Antonov, A. V., Knight, R. A., Melino, G., Barlev, N. A., & Tsvetkov, P. O. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.137 · Cited by 66
microRNA-34a Sensitizes Lung Cancer Cell Lines to DDP Treatment Independent of p53 Status
Wang, X., Dong, K., Gao, P., Long, M., Fang, L., Weng, Y., Ouyang, Y., Ren, J.-H., & Zhang, H. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1218 · Cited by 51
MicroRNA-34a Suppresses Cell Proliferation by Targeting LMTK3 in Human Breast Cancer MCF-7 Cell Line
Zhao, G.-Q., Guo, J., Li, D., Jia, C., Yin, W., Sun, R., Lv, Z., & Cong, X. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2130 · Cited by 48
Lu, X., Chen, K., Liang, H., Li, Z., Zou, X., Luo, H., Guo, W., & Xu, L. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.005 · Cited by 19
Cited by
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Metadata
- Authors
- Li, X. J., Ren, Z. J., & Tang, J. H.
- Venue
- Cell Death & Disease
- Published
- 2014-07-17
- Volume
- 5
- Issue
- 7
- Pages
- e1327-e1327
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2051599263
- Cited by
- 287
- References
- 89
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.